Biomedical tissue: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
:''See also: [[Biomedical material]] and [[Implant (medicine)]] | :''See also: [[Biomedical material]] and [[Implant (medicine)]] | ||
| Line 12: | Line 12: | ||
The regulation of human transplantation in the United Kingdom is set out in the Human Tissue Act 2004 and managed by the [[Human Tissue Authority]].<ref name="HTA-remit">{{cite web |author=Human Tissue Authority |authorlink=Human Tissue Authority |title=Remit |url=http://www.hta.gov.uk/aboutus/remit/}}</ref> | The regulation of human transplantation in the United Kingdom is set out in the Human Tissue Act 2004 and managed by the [[Human Tissue Authority]].<ref name="HTA-remit">{{cite web |author=Human Tissue Authority |authorlink=Human Tissue Authority |title=Remit |url=http://www.hta.gov.uk/aboutus/remit/}}</ref> | ||
Tissue banks in the [[United States|US]] are monitored by the [[Food and Drug Administration]] (FDA). The Code of Federal Regulations sets out the following topics:<ref name="CFR2003">{{cite web |author=Food and Drug Administration |authorlink=Food and Drug Administration |title=Part 1270: 'Human Tissue Intended for Transplantation' |year=2003 |work=Title 21--Food and Drugs |publisher= | Tissue banks in the [[United States|US]] are monitored by the [[Food and Drug Administration]] (FDA). The Code of Federal Regulations sets out the following topics:<ref name="CFR2003">{{cite web |author=Food and Drug Administration |authorlink=Food and Drug Administration |title=Part 1270: 'Human Tissue Intended for Transplantation' |year=2003 |work=Title 21--Food and Drugs |publisher=Code of Federal Regulations |url=http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr1270_03.html}}</ref> | ||
* Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation. | * Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation. | ||
* Procedures and Records: the written procedures and records that must be kept | * Procedures and Records: the written procedures and records that must be kept | ||
| Line 24: | Line 24: | ||
==Footnotes== | ==Footnotes== | ||
{{reflist}} | {{reflist|2}} | ||
{{Organ transplantation}} | {{Organ transplantation}} | ||
[[Category:Tissues]] | [[Category:Tissues]] | ||
Latest revision as of 14:47, 4 September 2012
|
WikiDoc Resources for Biomedical tissue |
|
Articles |
|---|
|
Most recent articles on Biomedical tissue Most cited articles on Biomedical tissue |
|
Media |
|
Powerpoint slides on Biomedical tissue |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Biomedical tissue |
|
Clinical Trials |
|
Ongoing Trials on Biomedical tissue at Clinical Trials.gov Trial results on Biomedical tissue Clinical Trials on Biomedical tissue at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Biomedical tissue NICE Guidance on Biomedical tissue
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Biomedical tissue Discussion groups on Biomedical tissue Patient Handouts on Biomedical tissue Directions to Hospitals Treating Biomedical tissue Risk calculators and risk factors for Biomedical tissue
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Biomedical tissue |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
- See also: Biomedical material and Implant (medicine)
Biomedical tissue is biological tissue used for organ transplantation and medical research, particularly cancer research.
Such tissues and organs may be referred to as: implant tissue, allograft, xenograft, skin graft tissue, human transplant tissue, implant bone. Tissue is stored in tissue establishments or tissue banks under cryogenic conditions. Fluids such as blood, blood products and urine are stored in fluid banks under similar conditions.
Regulation
The collection, storage, analysis and transplantation of human tissue involves significant ethical and safety issues, and is heavily regulated. Each country sets its own framework for ensuring the safety of human tissue products.
The regulation of human transplantation in the United Kingdom is set out in the Human Tissue Act 2004 and managed by the Human Tissue Authority.[1]
Tissue banks in the US are monitored by the Food and Drug Administration (FDA). The Code of Federal Regulations sets out the following topics:[2]
- Donor Screening and Testing: the determination of donor suitability for human tissue intended for transplantation.
- Procedures and Records: the written procedures and records that must be kept
- Inspection of Tissue Establishments: the importation of tissues from abroad and the retention, recall, and destruction of human tissue.
Notable regulation cases
- Biomedical Tissue Services, Inc. is at the heart of an investigation by the Food and Drug Administration. [1]
External links
Footnotes
- ↑ Human Tissue Authority. "Remit".
- ↑ Food and Drug Administration (2003). "Part 1270: 'Human Tissue Intended for Transplantation'". Title 21--Food and Drugs. Code of Federal Regulations.